authors
- Garcia, Jacqueline S
- Swords, Ronan T
- Roboz, Gail J
- Jacoby, Meagan A
- Garcia-Manero, Guillermo
- Hong, Wan-Jen
- Yang, Xiaoqing
- Zhou, Ying
- Platzbecker, Uwe
- Steensma, David P
- Wolff, Johannes E
- Fenaux, Pierre
Corrigendum to "A systematic review of higher-risk myelodysplastic syndromes clinical trials to determine the benchmark of azacitidine and explore alternative endpoints for overall survival" [Leukemia Res. 104 March (2021)].
Article
Overview
publication date
- April 23, 2021
published in
- Leukemia research Journal
Identity
Scopus Document Identifier
- 85107088681
Digital Object Identifier (DOI)
- 10.1016/j.leukres.2021.106581
PubMed ID
- 33896620
Additional Document Info
volume
- 105